Trial Profile
Comparing the Effects of an Immunosuppressant (Mycophenolate Mofetil or MMF) on the Urinary Sodium Excretion Response to Mental Stress in a Crossover Design (MMF)
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Jun 2021
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 03 Jun 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified June 2019).
- 19 Jun 2019 Planned End Date changed from 1 Apr 2019 to 30 Nov 2019.
- 19 Jun 2019 Planned primary completion date changed from 1 Apr 2019 to 1 Nov 2019.